However, UBR5 amplification is the predominant genetic alteration in many types of cancers (far more prevalent than loss-of-function UBR5 mutations), and amplified UBR5 correlates with poor outcomes in breast cancer (Shearer et al., 2015). This evidence concerns the gene UBR5 and breast carcinoma.